Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
ACTU
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -75.2%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
actuate
therapeutics
elraglusib
clinical
phase
data
present
2025
trial
treatment
refractory
million
annual
meeting
survival
drug
citizens
life
sciences
conference
A
ACTU
Actuate Therapeutics, Inc. Common stock
Stonvex
StonvexStonvexStonvexStonvex